BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21985151)

  • 21. A potent enzybiotic against methicillin-resistant Staphylococcus aureus.
    Kaur J; Singh P; Sharma D; Harjai K; Chhibber S
    Virus Genes; 2020 Aug; 56(4):480-497. PubMed ID: 32367411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization and complete genome of the virulent Myoviridae phage JD007 active against a variety of Staphylococcus aureus isolates from different hospitals in Shanghai, China.
    Cui Z; Feng T; Gu F; Li Q; Dong K; Zhang Y; Zhu Y; Han L; Qin J; Guo X
    Virol J; 2017 Feb; 14(1):26. PubMed ID: 28179010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LysSYL: a broad-spectrum phage endolysin targeting Staphylococcus species and eradicating S. aureus biofilms.
    Liu H; Wei X; Wang Z; Huang X; Li M; Hu Z; Zhang K; Hu Q; Peng H; Shang W; Yang Y; Wang Y; Lu S; Rao X
    Microb Cell Fact; 2024 Mar; 23(1):89. PubMed ID: 38528536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The lytic activity of recombinant phage lysin LysKΔamidase against staphylococcal strains associated with bovine and human infections in the Jiangsu province of China.
    Zhou Y; Zhang H; Bao H; Wang X; Wang R
    Res Vet Sci; 2017 Apr; 111():113-119. PubMed ID: 28235706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a bacteriophage, isolated from a cow with mastitis, that is lytic against Staphylococcus aureus strains.
    Kwiatek M; Parasion S; Mizak L; Gryko R; Bartoszcze M; Kocik J
    Arch Virol; 2012 Feb; 157(2):225-34. PubMed ID: 22045271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lytic activity of the recombinant staphylococcal bacteriophage PhiH5 endolysin active against Staphylococcus aureus in milk.
    Obeso JM; Martínez B; Rodríguez A; García P
    Int J Food Microbiol; 2008 Dec; 128(2):212-8. PubMed ID: 18809219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of Host Range Expansion of Therapeutic Bacteriophage Sb-1 with Allele State at a Hypervariable Repeat Locus.
    Sergueev KV; Filippov AA; Farlow J; Su W; Kvachadze L; Balarjishvili N; Kutateladze M; Nikolich MP
    Appl Environ Microbiol; 2019 Nov; 85(22):. PubMed ID: 31492663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterizations of the endolysin Lys84 and its domains from phage qdsa002 with high activities against Staphylococcus aureus and its biofilms.
    Ning H; Lin H; Wang J; He X; Lv X; Ju L
    Enzyme Microb Technol; 2021 Aug; 148():109809. PubMed ID: 34116743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Auxiliary Role of the Amidase Domain in Cell Wall Binding and Exolytic Activity of Staphylococcal Phage Endolysins.
    Son B; Kong M; Ryu S
    Viruses; 2018 May; 10(6):. PubMed ID: 29799482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted Antimicrobial Photodynamic Therapy of Biofilm-Embedded and Intracellular Staphylococci with a Phage Endolysin's Cell Binding Domain.
    Bispo M; Santos SB; Melo LDR; Azeredo J; van Dijl JM
    Microbiol Spectr; 2022 Feb; 10(1):e0146621. PubMed ID: 35196798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation and evaluation of the efficacy of bacteriophages against multidrug-resistant (MDR), methicillin-resistant (MRSA) and biofilm-producing strains of Staphylococcus aureus recovered from bovine mastitis.
    Mohammadian F; Rahmani HK; Bidarian B; Khoramian B
    BMC Vet Res; 2022 Nov; 18(1):406. PubMed ID: 36384653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 HydH5 virion-associated peptidoglycan hydrolase: fusions, deletions, and synergy with LysH5.
    Rodríguez-Rubio L; Martínez B; Rodríguez A; Donovan DM; García P
    Appl Environ Microbiol; 2012 Apr; 78(7):2241-8. PubMed ID: 22267667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lytic activity of the staphylolytic Twort phage endolysin CHAP domain is enhanced by the SH3b cell wall binding domain.
    Becker SC; Swift S; Korobova O; Schischkova N; Kopylov P; Donovan DM; Abaev I
    FEMS Microbiol Lett; 2015 Jan; 362(1):1-8. PubMed ID: 25790497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotypic and Genotypic Characterization of Novel Polyvalent Bacteriophages With Potent
    Whittard E; Redfern J; Xia G; Millard A; Ragupathy R; Malic S; Enright MC
    Front Cell Infect Microbiol; 2021; 11():698909. PubMed ID: 34295840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. APTC-C-SA01: A Novel Bacteriophage Cocktail Targeting
    Liu S; Hon K; Bouras GS; Psaltis AJ; Shearwin K; Wormald PJ; Vreugde S
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals.
    O'Flaherty S; Ross RP; Meaney W; Fitzgerald GF; Elbreki MF; Coffey A
    Appl Environ Microbiol; 2005 Apr; 71(4):1836-42. PubMed ID: 15812009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global Transcriptomic Analysis of Bacteriophage-Host Interactions between a Kayvirus Therapeutic Phage and Staphylococcus aureus.
    Finstrlová A; Mašlaňová I; Blasdel Reuter BG; Doškař J; Götz F; Pantůček R
    Microbiol Spectr; 2022 Jun; 10(3):e0012322. PubMed ID: 35435752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Staphylococcus aureus Prophage-Encoded Protein Causes Abortive Infection and Provides Population Immunity against Kayviruses.
    Kuntová L; Mašlaňová I; Obořilová R; Šimečková H; Finstrlová A; Bárdy P; Šiborová M; Troianovska L; Botka T; Gintar P; Šedo O; Farka Z; Doškař J; Pantůček R
    mBio; 2023 Apr; 14(2):e0249022. PubMed ID: 36779718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic potential of bacteriophages for staphylococcal infections and selected methods for in vitro susceptibility testing of staphylococci.
    Dvořáčková M; Růžička F; Dvořáková Heroldová M; Vacek L; Bezděková D; Benešík M; Petráš P; Pantůček R
    Epidemiol Mikrobiol Imunol; 2020; 69(1):10-18. PubMed ID: 32326711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overcoming bacteriophage insensitivity in Staphylococcus aureus using clindamycin and azithromycinat subinhibitory concentrations.
    Liu S; Zhao Y; Hayes A; Hon K; Zhang G; Bennett C; Hu H; Finnie J; Morales S; Shearwin L; Psaltis AJ; Shearwin K; Wormald PJ; Vreugde S
    Allergy; 2021 Nov; 76(11):3446-3458. PubMed ID: 33930199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.